HPLC MS Method for Analysis of Procainamide on Primesep 200 Column
Separation type: Liquid Chromatography Mixed-mode SIELC Technologies
High Performance Liquid Chromatography (HPLC) Method for Analysis of Procainamide
Procainamide is a medication that belongs to the class of antiarrhythmic drugs. It is used to treat certain types of irregular heartbeats (arrhythmias), particularly those associated with atrial and ventricular fibrillation or atrial flutter. Procainamide works by stabilizing the heart’s electrical activity and helping to restore a normal rhythm.
Procainamide blocks sodium channels in the heart, which helps to slow down the conduction of electrical impulses. By doing so, it can prevent abnormal electrical activity in the heart.
Procainamide can be retained and analyzed using a Primesep 200 mixed-mode stationary phase column. The analysis employs an isocratic method with a simple mobile phase comprising water, acetonitrile (MeCN), and ammonium formate as a buffer. This method allows for detection using UV at 280 nm
Column | Primesep 200, 2.1 x 100 mm, 5 µm, 100 A |
Mobile Phase | Gradient MeCN 30-60%, 10 min |
Buffer | AmFm pH 3.0 – 10 mM |
Flow Rate | 0.2 ml/min |
Detection | UV 280nm, SIM + 236 |
Samples | 0.15mg/ml |
Injection volume | 5 µl |
LOD* | 30 ppb |
Class of Compounds | Antiarrhythmic agent, Amide |
Analyzing Compounds | Procainamide |
Application Column
Primesep 200
Column Diameter: 2.1 mm
Column Length: 100 mm
Particle Size: 5 µm
Pore Size: 100 A
LC MS Detection